Track topics on Twitter Track topics that are important to you
Webinar starts at 2 p.m. ET on April 24
Workers’ compensation payers use metrics for predictive modeling, to identify opioid overuse, and measure the effectiveness of all kinds of programs. However, few understand how to measure the performance of their Medicare Secondary Payer (MSP) and Medicare Set-Asides (MSA) programs and use this information to reverse engineer improvements in claims management.
Tower MSA Partners’ President Rita Wilson and Chief Compliance Officer Daniel Anders will discuss this and other ways to optimize MSAs in an hour-long webinar “Leveraging Metrics and MSA Partner Relationship to Settle Claims” on Wednesday, April 24, at 2 p.m. ET.
Part of Tower’s quarterly Premier Webinar series, the educational session focuses on the need to measure the performance of an MSA program and identifies the key metrics needed.
“When you ask a payer the percentage of their CMS-approved MSAs that contain prescription drugs, and in particular, those that contain opioids, most can’t tell you,” said Wilson. “As major drivers of settlement cost, it is critical to measure these as key performance indicators in order to improve future outcomes.”
The webinar also shares ways to build a better relationship with the MSA provider to reduce allocations and improve the program performance.
“MSA drafting and review factors can impact a settlement program’s performance,” Anders said. “We’ll discuss these and offer simple strategies for how to work more effectively with your MSP company.”
There is no charge for the webinar and registration information can be found at https://register.gotowebinar.com/register/2259905811107508493. To receive notifications of future webinars, please sign up for Tower’s MSP Compliance Blog at https://towermsa.com/blog/.
About Tower MSA Partners
Headquartered in Delray Beach, Florida, Tower MSA Partners provides pre-MSA Triage, MSAs, physician peer reviews, CMS submissions, MSA administration, medical cost projections, life care plans, conditional payments, and Section 111 reporting. Tower leverages leading edge technology to proactively stage claims and works collaboratively with clients to identify issues and intervene to modify outcomes. Tower remains involved in the claims, through final resolution, MSA and/or other settlement. This model enables Tower’s clients to provide better care to injured workers, reduce claim and MSA costs, and obtain CMS acceptance of the MSA. For more information, call 888-331-4941 or visit www.towermsa.com or https://towermsa.com/blog/.
Helen King Patterson
King Knight Communications
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...